138 related articles for article (PubMed ID: 23749818)
21. A rare missense variant in RET exon 8 in a Portuguese family with atypical multiple endocrine neoplasia type 2A.
Martins AF; Martins JM; do Vale S; Dias T; Silveira C; da Silva IR; Carmo-Fonseca M
Hormones (Athens); 2016 Jul; 15(3):435-440. PubMed ID: 27838608
[TBL] [Abstract][Full Text] [Related]
22. [Molecular characterisation of a kindred with MEN2A and clinical implications].
Lemos MC; Carrilho F; Rodrigues FJ; Cavalheiro M; Regateiro FJ; Ruas MM
Acta Med Port; 2003; 16(4):245-50. PubMed ID: 22226210
[TBL] [Abstract][Full Text] [Related]
23. Tissue-specific carcinogenesis in transgenic mice expressing the RET proto-oncogene with a multiple endocrine neoplasia type 2A mutation.
Kawai K; Iwashita T; Murakami H; Hiraiwa N; Yoshiki A; Kusakabe M; Ono K; Iida K; Nakayama A; Takahashi M
Cancer Res; 2000 Sep; 60(18):5254-60. PubMed ID: 11016655
[TBL] [Abstract][Full Text] [Related]
24. Update multiple endocrine neoplasia type 2.
Raue F; Frank-Raue K
Fam Cancer; 2010 Sep; 9(3):449-57. PubMed ID: 20087666
[TBL] [Abstract][Full Text] [Related]
25. Non-invasive prenatal diagnosis of multiple endocrine neoplasia type 2A using COLD-PCR combined with HRM genotyping analysis from maternal serum.
Macher HC; Martinez-Broca MA; Rubio-Calvo A; Leon-Garcia C; Conde-Sanchez M; Costa A; Navarro E; Guerrero JM
PLoS One; 2012; 7(12):e51024. PubMed ID: 23236420
[TBL] [Abstract][Full Text] [Related]
26. A newly detected mutation of the RET protooncogene in exon 8 as a cause of multiple endocrine neoplasia type 2A.
Bethanis S; Koutsodontis G; Palouka T; Avgoustis C; Yannoukakos D; Bei T; Papadopoulos S; Linos D; Tsagarakis S
Hormones (Athens); 2007; 6(2):152-6. PubMed ID: 17704047
[TBL] [Abstract][Full Text] [Related]
27. Genetic prenatal RET testing and pregnancy management of multiple endocrine neoplasia Type II A (MEN2A): a case report.
Martinelli P; Maruotti GM; Pasquali D; Paladini D; Agangi A; Rippa E; Colantuoni V; Bellastella A; Sinisi AA
J Endocrinol Invest; 2004 Apr; 27(4):357-60. PubMed ID: 15233556
[TBL] [Abstract][Full Text] [Related]
28. MEN 2A-related cutaneous lichen amyloidosis: report of three kindred and systematic literature review of clinical, biochemical and molecular characteristics.
Scapineli JO; Ceolin L; Puñales MK; Dora JM; Maia AL
Fam Cancer; 2016 Oct; 15(4):625-33. PubMed ID: 26920351
[TBL] [Abstract][Full Text] [Related]
29. 5P Strategies for Management of Multiple Endocrine Neoplasia Type 2: A Paradigm of Precision Medicine.
Li SY; Ding YQ; Si YL; Ye MJ; Xu CM; Qi XP
Front Endocrinol (Lausanne); 2020; 11():543246. PubMed ID: 33071967
[TBL] [Abstract][Full Text] [Related]
30. A Homozygous RET K666N Genotype With an MEN2A Phenotype.
Jaber T; Hyde SM; Cote GJ; Grubbs EG; Giles WH; Stevens CA; Dadu R
J Clin Endocrinol Metab; 2018 Apr; 103(4):1269-1272. PubMed ID: 29408964
[TBL] [Abstract][Full Text] [Related]
31. Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary thyroid carcinoma.
Kinlaw WB; Scott SM; Maue RA; Memoli VA; Harris RD; Daniels GH; Porter DM; Belloni DR; Spooner ET; Ernesti MM; Noll WW
Clin Endocrinol (Oxf); 2005 Dec; 63(6):676-82. PubMed ID: 16343103
[TBL] [Abstract][Full Text] [Related]
32. Spectrum of Germline RET variants identified by targeted sequencing and associated Multiple Endocrine Neoplasia type 2 susceptibility in China.
Qi XP; Zhao JQ; Fang XD; Lian BJ; Li F; Wang HH; Cao ZL; Zheng WH; Cao J; Chen Y
BMC Cancer; 2021 Apr; 21(1):369. PubMed ID: 33827484
[TBL] [Abstract][Full Text] [Related]
33. Molecular genetic diagnostic program of multiple endocrine neoplasia type 2A and familial medullary thyroid carcinoma syndromes in Hungary.
Klein I; Esik O; Homolya V; Szeri F; Váradi A
J Endocrinol; 2001 Sep; 170(3):661-6. PubMed ID: 11524247
[TBL] [Abstract][Full Text] [Related]
34. Multiple endocrine neoplasia type 2A in two families with the familial medullary thyroid carcinoma associated G533C mutation of the RET proto-oncogene.
Peppa M; Boutati E; Kamakari S; Pikounis V; Peros G; Panayiotides IG; Economopoulos T; Raptis SA; Hadjidakis D
Eur J Endocrinol; 2008 Dec; 159(6):767-71. PubMed ID: 18805915
[TBL] [Abstract][Full Text] [Related]
35. Multiple endocrine neoplasia type 2A due to an exon 8 (G533C) mutation in a large North American kindred.
Castro MR; Thomas BC; Richards ML; Zhang J; Morris JC
Thyroid; 2013 Dec; 23(12):1547-52. PubMed ID: 23461807
[TBL] [Abstract][Full Text] [Related]
36. Papillary thyroid carcinoma, parathyroid adenoma, and unexplained hypercalcitoninemia: an unusual presentation of multiple endocrine neoplasia type 2A?
Rone JK; Lane AG; Grinkemeyer MD
Thyroid; 1998 Sep; 8(9):781-5. PubMed ID: 9777749
[TBL] [Abstract][Full Text] [Related]
37. RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes.
Kim IJ; Kang HC; Park JH; Ku JL; Lee JS; Kwon HJ; Yoon KA; Heo SC; Yang HY; Cho BY; Kim SY; Oh SK; Youn YK; Park DJ; Lee MS; Lee KW; Park JG
Clin Cancer Res; 2002 Feb; 8(2):457-63. PubMed ID: 11839664
[TBL] [Abstract][Full Text] [Related]
38. Clinical spectrum of MEN2A in a large family caused by the infrequent RET mutation Cys609Phe.
Oriola J; Biarnes J; Hernandez C; Simó R
Clin Genet; 2013 Apr; 83(4):384-7. PubMed ID: 22734615
[TBL] [Abstract][Full Text] [Related]
39. RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds.
Fialkowski EA; DeBenedetti MK; Moley JF; Bachrach B
J Pediatr Surg; 2008 Jan; 43(1):188-90. PubMed ID: 18206480
[TBL] [Abstract][Full Text] [Related]
40. Pancreatitis as the first manifestation of multiple endocrine neoplasia type 2A.
Dora JM; Siqueira DR; Meyer EL; Puñales MK; Maia AL
Arq Bras Endocrinol Metabol; 2008 Nov; 52(8):1332-6. PubMed ID: 19169490
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
